Clinical trials recruiting for Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Biological NI-1801 | 1 |
| CDH17 CAR-T | 1 |
| FAST LACO-Stim CDH17 CAR-T | 1 |
| NI-1801 in combination with anti-PD1 (Pembrolizumab) | 1 |
| NI-1801 in combination with paclitaxel | 1 |
| Paclitaxel | 1 |
Self-screener
Recruiting trials
- A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
- CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Related conditions
Trials recruiting for Pancreatic Adenocarcinoma (Ductal Adenocarcinoma) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Adenocarcinoma (Ductal Adenocarcinoma) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.